Thermo Fisher Scientific reported a 10% revenue increase in Q2 2026, driven by 5% organic growth and improved margins. The company’s Pharma and Biotech sectors showed mid-single-digit gains, reflecting a market rebound. Recent acquisitions of Clario and Solventum’s Filtration and Separation business have expanded Thermo Fisher’s capabilities, enhancing customer spending share and revenue synergies. With reasonable valuation and expected 9-10% EPS growth, the stock presents an attractive risk/reward profile for investors.
Zcash surged 10% to over $1,616, leading major cryptocurrencies higher as Bitcoin held steady near $86,900. The positive momentum follows the US House Financial Services Committee's approval of a bill to create a Strategic Bitcoin Reserve and the SEC...
Anchorage Digital has chosen LayerZero as its preferred interoperability layer for stablecoins issued through its federally chartered bank, emphasizing the importance of regulated stablecoins for mass adoption by banks, payment firms, and corporate t...
Akash Network's token AKT surged 14.12% amid increased trading volume and investor interest driven by a broader rotation into AI and compute-focused tokens. Large market participants, or whales, boosted buying pressure, supporting the breakout from a...
A Vice President at WM sold 1,365 shares valued at $300,000. Insider sales like this can indicate the executive's personal financial decisions but do not necessarily reflect the company's outlook. Investors should watch for any further insider activi...
Discord is launching age verification for all users starting Wednesday, after delaying the plan due to privacy concerns over biometric scans and ID checks. The platform will use existing account data and machine learning to estimate age groups, avoid...
